StockData
iBio, Inc. logo

iBio, Inc. (IBIO) stock

IBIONasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/30
$0.75+0.04 (+5.86%)

Close on Nov 17, 2026Market cap $48.11MP/E –Yield –

iBio operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

iBio's operating cash flow for the twelve months ending Sep 30, 2026 was -$26.94M. For fiscal 2026 it was -$23.22M. The highest annual figure on record is -$4.12M in fiscal 2014.

Annual operating cash flow

PeriodPeriod endValueChange
FY2026Jun 30, 2026-$23.22M–
FY2025Jun 30, 2025-$15.30M–
FY2024Jun 30, 2024-$18.55M–
FY2023Jun 30, 2023-$30.44M–
FY2022Jun 30, 2022-$37.48M–
FY2021Jun 30, 2021-$30.06M–
FY2020Jun 30, 2020-$13.35M–
FY2019Jun 30, 2019-$13.98M–
FY2018Jun 30, 2018-$13.48M–
FY2017Jun 30, 2017-$13.16M–
FY2016Jun 30, 2016-$8.07M–
FY2015Jun 30, 2015-$4.73M–
FY2014Jun 30, 2014-$4.12M–
FY2013Jun 30, 2013-$4.85M–
FY2012Jun 30, 2012-$6.01M–
FY2011Jun 30, 2011-$5.34M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Sep 30, 2026-$9.39M–
Q4 FY2026CQ2 2026Jun 30, 2026-$6.23M–
Q3 FY2026CQ1 2026Mar 31, 2026-$6.08M–
Q2 FY2026CQ4 2025Dec 31, 2025-$5.24M–
Q1 FY2026CQ3 2025Sep 30, 2025-$5.67M–
Q4 FY2025CQ2 2025Jun 30, 2025-$4.62M–
Q3 FY2025CQ1 2025Mar 31, 2025-$3.11M–
Q2 FY2025CQ4 2024Dec 31, 2024-$3.87M–
Q1 FY2025CQ3 2024Sep 30, 2024-$3.72M–
Q4 FY2024CQ2 2024Jun 30, 2024-$4.85M–
Q3 FY2024CQ1 2024Mar 31, 2024-$3.65M–
Q2 FY2024CQ4 2023Dec 31, 2023-$4.71M–
Q1 FY2024CQ3 2023Sep 30, 2023-$5.34M–
Q4 FY2023CQ2 2023Jun 30, 2023-$4.97M–
Q3 FY2023CQ1 2023Mar 31, 2023-$3.87M–
Q2 FY2023CQ4 2022Dec 31, 2022-$7.64M–
Q1 FY2023CQ3 2022Sep 30, 2022-$13.96M–
Q4 FY2022CQ2 2022Jun 30, 2022-$11.50M–
Q3 FY2022CQ1 2022Mar 31, 2022-$5.94M–
Q4 FY2021CQ2 2021Jun 30, 2021-$7.23M–
Q3 FY2021CQ1 2021Mar 31, 2021-$7.35M–
Q2 FY2021CQ4 2020Dec 31, 2020-$8.42M–
Q1 FY2021CQ3 2020Sep 30, 2020-$7.07M–
Q4 FY2020CQ2 2020Jun 30, 2020-$3.87M–
Q3 FY2020CQ1 2020Mar 31, 2020-$3.79M–
Q2 FY2020CQ4 2019Dec 31, 2019-$3.41M–
Q1 FY2020CQ3 2019Sep 30, 2019-$2.29M–
Q4 FY2019CQ2 2019Jun 30, 2019-$4.39M–
Q3 FY2019CQ1 2019Mar 31, 2019-$4.14M–
Q2 FY2019CQ4 2018Dec 31, 2018-$4.67M–
Q1 FY2019CQ3 2018Sep 30, 2018-$778.00K–
Q4 FY2018CQ2 2018Jun 30, 2018-$3.38M–
Q3 FY2018CQ1 2018Mar 31, 2018-$3.50M–
Q2 FY2018CQ4 2017Dec 31, 2017-$3.59M–
Q1 FY2018CQ3 2017Sep 30, 2017-$3.02M–
Q4 FY2017CQ2 2017Jun 30, 2017-$3.77M–
Q3 FY2017CQ1 2017Mar 31, 2017-$3.56M–
Q2 FY2017CQ4 2016Dec 31, 2016-$3.56M–
Q1 FY2017CQ3 2016Sep 30, 2016-$2.27M–

More iBio figures

See a number that looks wrong?